May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
TELEMETRY–BASED CONTINUOUS PRESSURE MONITORING AS A TOOL TO REVEAL DORZOLAMIDE–INDUCED INTRAOCULAR PRESSURE CHANGES IN OCULAR HYPERTENSIVE CYNOMOLGUS MONKEYS.
Author Affiliations & Notes
  • M. Neuner–Jehle
    Disease Area Ophthalmology, Novartis Institutes for Biomedical Research, Basel, Switzerland
  • C. Cojean
    Disease Area Ophthalmology, Novartis Institutes for Biomedical Research, Basel, Switzerland
  • I. Questel
    Disease Area Ophthalmology, Novartis Institutes for Biomedical Research, Basel, Switzerland
  • E. Faure
    Disease Area Ophthalmology, Novartis Institutes for Biomedical Research, Basel, Switzerland
  • G.N. Lambrou
    Disease Area Ophthalmology, Novartis Institutes for Biomedical Research, Basel, Switzerland
  • Footnotes
    Commercial Relationships  M. Neuner–Jehle, Novartis E; C. Cojean, Novartis E; I. Questel, Novartis E; E. Faure, Novartis E; G.N. Lambrou, Novartis E.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 2118. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Neuner–Jehle, C. Cojean, I. Questel, E. Faure, G.N. Lambrou; TELEMETRY–BASED CONTINUOUS PRESSURE MONITORING AS A TOOL TO REVEAL DORZOLAMIDE–INDUCED INTRAOCULAR PRESSURE CHANGES IN OCULAR HYPERTENSIVE CYNOMOLGUS MONKEYS. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):2118.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Intraocular pressure (IOP) assessment by radio–telemetry is a unique method to follow drug–induced IOP variations online and for several weeks without the adverse interference of anesthesia. We examined the sensitivity of this method to detect dorzolamide–induced daily IOP changes in ocular hypertensive cynomolgus monkeys. Methods: 3 adult male cynomolgus monkeys were housed under a 12–hour light/12–h dark cycle and standardised conditions. Ocular hypertension was induced unilaterally by argon laser photocoagulation of the trabeculum. The telemetry system was purchased from Transoma Inc., USA and implanted subcutaneously (battery/transmitter) and intravitreously (pressure transducer). In 2 independent studies, the IOP level is measured online during 21 days. On each of the 5 consecutive instillation days, TRUSOPTTM 2% eye drops were instilled twice (9 a.m. and 4 p.m.) in the hypertensive eyes. Drug–induced IOP variations were assessed by (i) the percentage of IOP decrease relative to baseline levels and (ii) the maximum amplitude of IOP variations. Results: In both studies, an average dorzolamide–induced IOP decrease of approx. 50% of baseline values was observed both during the day and in the night. There is an individual component to the response on the drug in as far as during the instillation week, 2 monkeys showed a lowering of both mean IOP levels and amplitude of the daily IOP variations whereas 1 monkey repeatedly revealed only a decreased amplitude. At the end of the instillation period, the IOP returned to baseline levels within 3 days in all 3 monkeys. Conclusions: The results show that the described telemetry method is sensitive enough to detect the daily variations of the IOP level as well as the typical IOP response to dorzolamide in the ocular hypertensive monkey model.

Keywords: intraocular pressure • pathology: experimental • drug toxicity/drug effects 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×